Endovia Health Sciences, Inc.
EDVA· NYSE
EDVAEndovia Health Sciences, Inc.
Quarterly figures for Endovia Health Sciences, Inc., with source filings when available.
58 quarters. Mar 31, 2012 to Jun 30, 2026. USD.
Endovia Health Sciences, Inc. has filed its 10-Q within 45 to 102 days of period end across its last 8 quarters. The 10-K runs 67 to 105 days.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 19, 2026 | 50 d | 10-Q | $0.00 | — | -$0.77 | |
| Q1 2026 | Mar 31, 2026 | — | May 20, 2026 | 50 d | 10-Q | $4.22K | −93.8% | -$0.47 |
|---|
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | — | Apr 15, 2026 | 105 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 19, 2025 | 50 d | 10-Q | $393.07K | −60.0% | -$4.51 | |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | — | — | -$17.88 | |
| Q1 2025 | Mar 31, 2025 | — | Jul 11, 2025 | 102 d | 10-Q | $68.61K | −95.5% | -$1.97 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Jul 11, 2025 | 192 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 15, 2024 | 46 d | 10-Q | $981.86K | −80.9% | -$3.55 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | $1.05M | −79.9% | -$4.34 | |
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $1.54M | −73.5% | -$4.17 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Mar 29, 2024 | 89 d | 10-K | $2.69M | −43.9% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 14, 2023 | 45 d | 10-Q | $5.14M | +5.6% | -$0.13 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $5.19M | +15.5% | -$0.13 | |
| Q1 2023 | Mar 31, 2023 | — | Jun 6, 2023 | 67 d | 10-Q | $5.82M | +48.3% | -$0.10 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | $4.79M | +72.2% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | $4.87M | +72.3% | -$0.14 | |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | $4.50M | +36.8% | -$0.16 | |
| Q1 2022 | Mar 31, 2022 | Apr 1, 2022 · after-hours | May 16, 2022 | 46 d | 10-Q | $3.93M | +62.4% | -$0.16 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 31, 2022 | 90 d | 10-K | $2.78M | +124.1% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | $2.83M | +180.0% | — | |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | $3.29M | +436.9% | -$0.25 | |
| Q1 2021 | Mar 31, 2021 | — | May 12, 2021 | 42 d | 10-Q | $2.42M | +2,058.6% | -$0.19 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 8, 2021 | 67 d | 10-K | $1.24M | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 13, 2020 | 44 d | 10-Q | $1.01M | +230.8% | -$0.04 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 13, 2020 | 44 d | 10-Q | $612.31K | +1,331.5% | -$0.02 | |
| Q1 2020 | Mar 31, 2020 | — | May 13, 2020 | 43 d | 10-Q | $112.00K | +4,102.7% | -$0.05 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 27, 2020 | 87 d | 10-K | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 14, 2019 | 45 d | 10-Q | $305.20K | −2.5% | -$0.03 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | $42.78K | −87.9% | -$0.01 | |
| Q1 2019 | Mar 31, 2019 | — | May 21, 2019 | 51 d | 10-Q | $2.67K | −99.2% | -$0.02 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 29, 2019 | 88 d | 10-K | $296.80K | +90.6% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | 45 d | 10-Q | $312.99K | −1.9% | $0.00 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 20, 2018 | 51 d | 10-Q | $354.77K | +68.5% | $0.01 | |
| Q1 2018 | Mar 31, 2018 | — | May 15, 2018 | 45 d | 10-Q | $344.62K | +64.1% | $0.00 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Apr 2, 2018 | 92 d | 10-K | $155.70K | −44.5% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 13, 2017 | 44 d | 10-Q | $319.02K | +35.1% | $0.00 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 18, 2017 | 49 d | 10-Q | $210.57K | −10.8% | $0.00 | |
| Q1 2017 | Mar 31, 2017 | — | May 18, 2017 | 48 d | 10-Q | $210.06K | −19.1% | -$0.01 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Mar 28, 2017 | 87 d | 10-K | $280.52K | +1.2% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 21, 2016 | 52 d | 10-Q | $236.06K | +7.7% | $0.00 | |
| Q2 2016 | Jun 30, 2016 | — | Nov 15, 2016 | 138 d | 10-Q | $236.06K | +24.8% | $0.00 | |
| Q1 2016 | Mar 31, 2016 | — | Nov 15, 2016 | 229 d | 10-Q | $259.65K | +22.5% | $0.00 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Oct 3, 2016 | 277 d | 10-K | $277.28K | +66.7% | — | |
| Q3 2015 | Sep 30, 2015 | — | Oct 27, 2016 | 393 d | 10-Q | $219.11K | +56.8% | $0.00 | |
| Q2 2015 | Jun 30, 2015 | — | Oct 14, 2016 | 472 d | 10-Q | $189.08K | +32.0% | $0.00 | |
| Q1 2015 | Mar 31, 2015 | — | Oct 11, 2016 | 560 d | 10-Q | $211.88K | +35.3% | $0.00 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Sep 21, 2016 | 630 d | 10-K | $166.33K | −6.4% | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 19, 2014 | 50 d | 10-Q | $139.74K | −1.5% | $0.00 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 19, 2014 | 50 d | 10-Q | $143.20K | +73.9% | $0.00 | |
| Q1 2014 | Mar 31, 2014 | — | May 20, 2014 | 50 d | 10-Q | $156.64K | +113.5% | $0.00 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Apr 15, 2014 | 105 d | 10-K | $177.69K | +179.4% | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 13, 2013 | 44 d | 10-Q | $141.85K | +58.2% | $0.00 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 2, 2013 | 33 d | 10-Q | $82.37K | +4.0% | $0.00 | |
| Q1 2013 | Mar 31, 2013 | — | May 9, 2013 | 39 d | 10-Q | $73.35K | −3.8% | $0.00 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | Apr 15, 2013 | 105 d | 10-K | $63.60K | — | — | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $89.65K | — | $0.00 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $79.22K | — | $0.00 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $76.26K | — | $0.00 | |
